BCRP
E241383
ATP-binding cassette transporter
drug transporter
efflux transporter
membrane protein
multidrug resistance protein
BCRP (Breast Cancer Resistance Protein) is an ATP-binding cassette (ABC) efflux transporter involved in multidrug resistance and the transport of various drugs and xenobiotics across cellular membranes.
All labels observed (6)
| Label | Occurrences |
|---|---|
| ABCG2 | 1 |
| ATP-binding cassette sub-family G member 2 | 1 |
| ATP-binding cassette transporter family | 1 |
| BCRP canonical | 1 |
| Breast Cancer Resistance Protein | 1 |
| breast cancer resistance protein | 1 |
Statements (52)
| Predicate | Object |
|---|---|
| instanceOf |
ATP-binding cassette transporter
ⓘ
drug transporter ⓘ efflux transporter ⓘ membrane protein ⓘ multidrug resistance protein ⓘ |
| alsoKnownAs |
BCRP
ⓘ
surface form:
ABCG2
BCRP ⓘ
surface form:
ATP-binding cassette sub-family G member 2
BCRP ⓘ
surface form:
Breast Cancer Resistance Protein
|
| associatedWith |
chemotherapy resistance
ⓘ
gout susceptibility via urate transport ⓘ reduced intracellular drug accumulation ⓘ |
| belongsToFamily |
BCRP
self-linksurface differs
ⓘ
surface form:
ATP-binding cassette transporter family
|
| belongsToSubfamily | ABC subfamily G ⓘ |
| biologicalRole |
contribution to pharmacokinetic variability
ⓘ
efflux of drugs ⓘ efflux of xenobiotics ⓘ limitation of oral drug absorption ⓘ modulation of drug disposition ⓘ multidrug resistance in cancer cells ⓘ protection of tissues from toxic compounds ⓘ |
| containsDomain | nucleotide-binding domain ⓘ |
| effectOfPolymorphism |
altered drug pharmacokinetics
ⓘ
altered transporter expression ⓘ |
| encodedBy | ABCG2 gene ⓘ |
| inhibitedBy |
Ko143
ⓘ
cyclosporine A ⓘ elacridar ⓘ tyrosine kinase inhibitors ⓘ |
| localization |
apical membrane of epithelial cells
ⓘ
blood–brain barrier endothelial cells ⓘ hematopoietic stem cells ⓘ intestinal epithelium ⓘ kidney proximal tubule epithelium ⓘ liver canalicular membrane ⓘ placental syncytiotrophoblast ⓘ plasma membrane ⓘ |
| organism | Homo sapiens ⓘ |
| polymorphism | ABCG2 c.421C>A (Q141K) ⓘ |
| structure | half-transporter requiring homodimerization ⓘ |
| substrateOf |
estrone-3-sulfate
ⓘ
fluoroquinolone antibiotics ⓘ imatinib ⓘ irinotecan and its metabolites ⓘ methotrexate ⓘ mitoxantrone ⓘ rosuvastatin ⓘ sulfasalazine ⓘ topotecan ⓘ uric acid ⓘ |
| topology | six transmembrane helices per monomer ⓘ |
| transportMechanism | ATP-dependent efflux ⓘ |
| usesEnergyFrom | ATP hydrolysis ⓘ |
Referenced by (6)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Breast Cancer Resistance Protein
this entity surface form:
ABCG2
this entity surface form:
ATP-binding cassette sub-family G member 2
this entity surface form:
ATP-binding cassette transporter family
this entity surface form:
breast cancer resistance protein